U.S. Markets close in 5 hrs, 30 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 9,975.58 | -83.06 | -0.83% |
| NASDAQ | 2,133.94 | -16.93 | -0.79% |
| S&P 500 | 1,060.62 | -9.90 | -0.92% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 2.37 09:30 AM EST | |
|---|---|---|
| Day High | 2.43 09:30 AM EST |
|
| Range | 0.06 |
| Volume | 10,779 | |
|---|---|---|
| 30-Day Avg Vol | 166,000 |
|
| Difference | -93.51% |
| Market Cap | 105.30 M | |
|---|---|---|
| Mkt Cap Chg | 881,238 |
| Shares Out | 44.06 M | |
|---|---|---|
| % Shrs Traded | 0.02% | |
| 1yr EPS Est | -0.788 |
| 52-Wk Low | 1.94 | |
|---|---|---|
| 52-Wk High | 4.25 |
|
| Range | 2.31 |
| Prev Close | 2.37 2/9/10 | |
|---|---|---|
| Today's Open | 2.37 | |
| Change | 0.00% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.16 M |
| Revenue (LFY) | 2.95 M | |
|---|---|---|
| Earnings (LFY) | -51.04 M | |
| Earnings (MRQ) | -7.92 M | |
| Next Earn Est | -0.242 | |
| Next Earnings | 05/05/2010 |
|
| EPS (TTM) | -1.30 | |
| 1yr EPS Growth | 39.85% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -3.00 | |
| PEG Ratio | — | |
| Return on Equity | -113.47 | |
| Beta | 0.66 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
For Neurocrine Biosciences, biology is all chemistry. The development-stage biotech develops treatments for neurological and endocrine-related diseases, such as insomnia, depression, and pain. Lead drug ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.242 5/5/10 | — — |
—
—
|
| Last Quarter | -0.274 12/31/09 | -0.20 12/31/09 |
0.074
Beat
|
| 2 Quarters Ago | -0.352 9/30/09 | -0.21 9/30/09 |
0.142
Beat
|
| Quarterly - 12/31/2009 | Annual - 2009 | |
|---|---|---|
| Total Revenue | 740,000.00 | 2.95 M |
| Gross Profit | 740,000.00 | 2.95 M |
| Operating Income | -8.85 M | -47.69 M |
| Net Income | -7.92 M | -51.04 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts